Want to see HK:1846 full AI Analyst Report?
1846 Stock Chart & Stats
HK$3.00
-HK$0.02(-0.53%)
At close: 4:00 PM EST
HK$3.00
-HK$0.02(-0.53%)
Day’s Range― - ―
52-Week RangeHK$2.26 - HK$3.46
Previous CloseN/A
Volume15.00K
Average Volume (3M)156.72K
Market Cap
HK$799.43M
Enterprise ValueHK$470.71M
Total Cash (Recent Filing)HK$696.70M
Total Debt (Recent Filing)HK$410.19M
Price to Earnings (P/E)14.7
Beta0.18
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.76%
Share Statistics
EPS (TTM)0.17
Shares Outstanding320,706,000
10 Day Avg. Volume164,000
30 Day Avg. Volume156,720
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.78
Price to Sales (P/S)1.22
P/FCF Ratio6.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationEuroEyes has produced steady operating cash flow across multiple years and delivered higher free cash flow in 2025. Persistent positive cash generation supports reinvestment in clinics, funds capital expenditure and debt servicing, and underpins resilience through cycles in elective healthcare demand.
Solid Balance Sheet Equity CushionA sizable equity base relative to assets gives financial flexibility to expand clinics and absorb operational shocks. Historically moderate leverage implies capacity to fund growth or absorb volatility without immediate refinancing pressure, supporting longer-term strategic options.
Renewed Revenue GrowthReturn to positive top-line growth signals recovering patient volumes or pricing power in elective refractive services. Sustained revenue expansion helps leverage fixed clinic costs and is a prerequisite for restoring prior margin and profit levels over the medium term.
Bears Say
Sharply Weakened Returns On EquityFalling ROE reflects reduced capital efficiency and weaker earnings relative to equity invested. If persistent, lower ROE can constrain shareholder returns, reduce internal capital efficacy for clinic rollouts, and require management to address structural profitability drivers.
Rising Absolute Debt In 2025An uptick in total debt raises financing costs and reduces headroom for opportunistic investments. Combined with weaker profitability, higher absolute leverage elevates refinancing and interest-rate sensitivity risk, pressuring cash flow allocation toward debt servicing.
Profit And Margin CompressionEarnings decline despite revenue growth signals margin pressure from higher costs, mix shifts, or lower pricing power. Persistent margin compression undermines free cash flow upside and return restoration prospects, requiring operational improvements or cost controls to re-establish prior profitability.
EuroEyes International Eye Clinic Limited News
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
EuroEyes International Eye Clinic Limited lowest stock price was HK$2.26 and its highest was HK$3.46 in the past 12 months.
What is EuroEyes International Eye Clinic Limited’s market cap?
EuroEyes International Eye Clinic Limited’s market cap is HK$799.43M.
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
EuroEyes International Eye Clinic Limited’s upcoming earnings report date is Aug 27, 2026 which is in 25 days.
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
EuroEyes International Eye Clinic Limited released its earnings results on Mar 31, 2026. The company reported HK$0.05 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.05.
Is EuroEyes International Eye Clinic Limited overvalued?
According to Wall Street analysts EuroEyes International Eye Clinic Limited’s price is currently Overvalued.
Does EuroEyes International Eye Clinic Limited pay dividends?
EuroEyes International Eye Clinic Limited pays a Quarterly dividend of HK$0.013 which represents an annual dividend yield of 1.76%. See more information on EuroEyes International Eye Clinic Limited dividends here
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
EuroEyes International Eye Clinic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding.
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
EuroEyes International Eye Clinic Limited reported an EPS of HK$0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.374%.
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
Currently, no hedge funds are holding shares in HK:1846
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EuroEyes International Eye Clinic Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.87%
12-Months-Change
Fundamentals
Return on Equity
1.76%
Trailing 12-Months
Asset Growth
22.06%
Trailing 12-Months
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
Technical Analysis
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―